Derma Sciences has submitted an application for 510(k) clearance to the US FDA for its latest product, the MediHoney Gel wound and burn dressing. The gel, which is intended for hard-to-dress areas and wounds, is dispensed from a tube, and is designed to stay at the wound site for extended periods of time, even in the presence of wound fluid. Like the other MediHoney products, it uses active Leptospermum honey as its antimicrobial agent. Princeton, New Jersey-based Derma Sciences expects a response from the agency within 90 days. The firm has also doubled its US sales force from 10 to 20 reps. The first MediHoney product was launched in the US in 2007.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?